The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis
Open accessAbstract
Importance: It is unclear whether female carriers of the apolipoprotein E (APOE) ε4 allele are at greater risk of developing Alzheimer disease (AD) than men, and the sex-dependent association of mild cognitive impairment (MCI) and APOE has not been established. Objective: To determine how sex and APOE genotype affect the risks for developing MCI and AD. Data Sources: Twenty-seven independent research studies in the Global Alzheimer's Association Interactive Network with data on nearly 58 000 participants. Study Selection: Non-Hispanic white individuals with clinical diagnostic and APOE genotype data. Data Extraction and Synthesis: Homogeneous data sets were pooled in case-control analyses, and logistic regression models were used to compute risks. Main Outcomes and Measures: Age-adjusted odds ratios (ORs) and 95% confidence intervals for developing MCI and AD were calculated for men and women across APOE genotypes. Results: Participants were men and women between ages 55 and 85 years. Across data sets most participants were white, and for many participants, racial/ethnic information was either not collected or not known. Men (OR, 3.09; 95% CI, 2.79-3.42) and women (OR, 3.31; CI, 3.03-3.61) with the APOE ε3/ε4 genotype from ages 55 to 85 years did not show a difference in AD risk; however, women had an increased risk compared with men between the ages of 65 and 75 years (women, OR, 4.37; 95% CI, 3.82-5.00; men, OR, 3.14; 95% CI, 2.68-3.67; P = .002). Men with APOE ε3/ε4 had an increased risk of AD compared with men with APOE ε3/ε3. The APOE ε2/ε3 genotype conferred a protective effect on women (OR, 0.51; 95% CI, 0.43-0.61) decreasing their risk of AD more (P value = .01) than men (OR, 0.71; 95% CI, 0.60-0.85). There was no difference between men with APOE ε3/ε4 (OR, 1.55; 95% CI, 1.36-1.76) and women (OR, 1.60; 95% CI, 1.43-1.81) in their risk of developing MCI between the ages of 55 and 85 years, but women had an increased risk between 55 and 70 years (women, OR, 1.43; 95% CI, 1.19-1.73; men, OR, 1.07; 95% CI, 0.87-1.30; P = .05). There were no significant differences between men and women in their risks for converting from MCI to AD between the ages of 55 and 85 years. Individuals with APOE ε4/ε4 showed increased risks vs individuals with ε3/ε4, but no significant differences between men and women with ε4/ε4 were seen. Conclusions and Relevance: Contrary to long-standing views, men and women with the APOE ε3/ε4 genotype have nearly the same odds of developing AD from age 55 to 85 years, but women have an increased risk at younger ages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE-e4 was related to higher Alzheimer's risk in women than men between ages 55 to 70”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [288]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Carrying one APOE4 allele increases the risk of AD by 3–4 times, and carrying two alleles increases the risk by 9–15 times.168”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [168]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Women are more vulnerable to effects of APOE4 on memory decline [45] as well as risk for AD dementia [16] and neuropathology [46], and more limited data suggest that APOE2 also confers greater protection against AD risk for women than men [16].”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“That is, APOE‐e4 was related to higher Alzheimer's risk in women than men between ages 55 and 70, when APOE is thought to exert its largest effects.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [314]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A recent meta-analysis found no difference between men and women in the association between APOE-e4 and Alzheimer's dementia overall, although age played an interesting interactive role.”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [288]
The cited source says what the claim attributes to it.
In the citing paper
“APOE is differentially associated with AD risk across populations [16]”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“Women are more vulnerable to effects of APOE4 on memory decline [45] as well as risk for AD dementia [16] and neuropathology [46], and more limited data suggest that APOE2 also confers greater protection against AD risk for women than men [16].”
From Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status (2024) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“However, a meta‐analysis found no difference between men and women in the association between APOE‐e4 and Alzheimer's dementia overall, although age played an interesting interactive role.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [314]
The cited source says what the claim attributes to it.
In the citing paper
“Epidemiologic studies show sex differences in clinical risk are largely discernable within the context of APOE ε4,11,42,43 particularly between the ages of 65 to 75 years compared with APOE ε4 clinically normal male carriers.44”
From Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) · cites this paper as [44]
In the citing paper
“Attempts to quantify the duration of AD should be age-specific, because age imposes the greatest risk for both dementia and mortality, and take into account APOE genotype, sex, and cerebrospinal fluid (CSF) tau levels [4, 6, 10-12].”
From Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype (2019) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. S. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,846
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
The normal menopause transition
McKinlay, S. M., Brambilla, D. J., & Posner, J. G. (1992) · Maturitas · doi:10.1016/0378-5122(92)90003-m · Cited by 1,112
Sex Differences in Stroke Epidemiology
Appelros, P., Stegmayr, B., & Terént, A. (2009) · Stroke · doi:10.1161/strokeaha.108.540781 · Cited by 1,076
Natural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037
Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021
Ellis, K. A., Bush, A. I., Darby, D., Fazio, D. D., Foster, J. K., Hudson, P. J., Lautenschlager, N. T., Lenzo, N. P., Martins, R. N., Maruff, P. T., et al. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009405 · Cited by 1,005
Cited by
Sorted by citations
Items 501–600 of 691
Kulminski, A. M., Jain‐Washburn, E., Philipp, I., Loika, Y., Loiko, E., & Culminskaya, I. V. (2024) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12600 · Cited by 2
Impact of APOE4‐related dementia risk in underrepresented groups from the All of Us research program
Ghisays, V., Khajouei, E., Piras, I. S., Malek‐Ahmadi, M. H., Protas, H. D., Goradia, D. D., Chen, Y., Naymik, M., Saner, D., Veatch, O. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70245 · Cited by 2
Self-citationZainuddin, M.-S., Ghanesh, K., Ganesan, N., Kumari, M., Radhakrishnan, A. K., & Bhuvanendran, S. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2526155 · Cited by 2
Esiaka, D. K., Strothkamp, S., Aghayeeabianeh, B., Broster, L. S., Powell, D. K., Jicha, G. A., & Jiang, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70912 · Cited by 2
Testosterone as a mediator of APOE4-linked sex differences in Alzheimer's disease
Shi, Z., Wu, L., Zhang, C., Zeng, X., Yao, G., He, X., Hu, J., Xie, T., & He, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115588 · Cited by 3
Mohammed, S. N., Direksunthorn, T., Zwamel, A. H., Uthirapathy, S., Ballal, S., Kalia, R., Arya, R., Naidu, K. S., Ahmad, I. S., & Ahmed, J. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05338-x · Cited by 3
Liu, L., Hou, J., Cui, S., Zhao, X., Liu, Z., Longenecker, J. C., May, N. S., Luo, J. J., DiMaria-Ghalili, R. A., & Eisen, H. J. (2025) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2025.101346 · Cited by 2
Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease
Zeng, Q., Wang, M., Wang, E., Zhou, X., Xu, P., Haroutunian, V. H., Cai, D., Zhang, B., Initiative, M. O. T. A. D. N., Weiner, M. W., et al. (2026) · GeroScience · doi:10.1007/s11357-025-02089-4 · Cited by 2
Orellana, P., Caviedes, A., Gonzalez, L., Ochoa‐Rosales, C., Carmona, D. J., Gonzalez‐Silva, C., Hernández, H., Britton, G. B., Villarreal, A. E., Campos, V., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71224 · Cited by 2
Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility
Milà‐Alomà, M., Hausle, I., Myoraku, A., Sorensen, C., Thropp, P., Shaw, L. M. J., Weiner, M. W., Tosun, D., & Initiative, A. D. N. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71244 · Cited by 2
Mostafaei, S., Shemer, D. W., Mak, J. K. L., Karlsson, I., & Hägg, S. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02011-w · Cited by 2
Sex differences in brain glucose metabolism and Alzheimer's disease risk and progression
Ramezan, M., Demetriou, A., Burke, S. N., Nalvarte, I., & Shin, A. C. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71491 · Cited by 2
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Drummond, E., Werry, E. L., Kavanagh, T., Genoud, S., Cho, A., Chen, S., Du, J., Hibbs, D. E., & Kassiou, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00035-y · Cited by 2
Simmons, K. E., Healey, K. L., Li, Q., Moore, S. D., & Klein, R. C. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14717 · Cited by 2
Gender differences in cognitive impairment among the elderly in rural West Texas counties
Khan, H. M. R., Farhana, F., Mostafa, F. B., Rafiq, A., Nizia, E. W., Zabin, Z., Atique, R., Dauenhauer, M., Omotara, O., Mujtaba, A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241305772 · Cited by 2
Apolipoprotein ɛ4 Allele and Subjective Cognitive Functioning in Parents of Adults With Disabilities
Song, J., Seltzer, M. M., & Greenberg, J. S. (2020) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbaa061 · Cited by 2
Zhang, X., Rawal, P., Wu, L., & Zhao, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818000-6.00007-x · Cited by 2
Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis
Ferré‐González, L., Peña‐Bautista, C., Álvarez‐Sánchez, L., Ferrer, I., Baquero, M., & Cháfer‐Pericás, C. (2021) · Antioxidants · doi:10.3390/antiox10111662 · Cited by 2
Harnessing diversity to study Alzheimer’s disease: A new iPSC resource from the NIH CARD and ADNI
Screven, L. A., Pantazis, C. B., Andersh, K. M., Hong, S., Vitale, D., Lara, E., Ku, R. Y., Heutink, P., Meyer, J. S., Faber, K. M., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.026 · Cited by 2
Wen, P., Han, C., Zhao, H., Yao, S., & Chen, H. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251384245 · Cited by 2
Cognitive disorders and dementia in postmenopausal women
Talipova, I. R., GARAFIEVA, S. M., Ирековна, М. М., & Mardieva, R. R. (2022) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2022.255 · Cited by 2
Modeling Alzheimer’s disease: considerations for a better translational and replicable mouse model
Santa‐María, I., Cho, J., & Yang, M. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335787 · Cited by 2
Cai, Y., Fu, P., & Zhang, X. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137161 · Cited by 3
Women at Greater Risk of Alzheimer’s: Way Forward
Ibeachu, C. P. (2023) · Sustainable development goals series · doi:10.1007/978-3-031-34963-8_4 · Cited by 3
Functional Glial Activation Mediates Phenotypic Effects of APOEɛ4 and Sex in Alzheimer’s Disease
Lane, R. M., Li, D. X., & Darreh‐Shori, T. (2024) · Neuroglia · doi:10.3390/neuroglia5030022 · Cited by 2
The neuron navigator 2 gene and Alzheimer's disease
Xu, C. D., Su, B., Lozano, S., & Wang, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00001-3 · Cited by 2
Sex differences in microglia as a risk factor for Alzheimer’s disease
Delage, C. I., Rendina, D. N., Malacon, K. E., Tremblay, M., & Bilbo, S. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00008-9 · Cited by 2
Murphy, A. J., Williamson, J. B., & Lamb, D. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_691 · Cited by 2
Batista, A. F., Presumey, J., Singh, B. B., Yalçın, E., Schroeder, M. K., Khan, K., Spooner, E., Li, S. A., Carroll, M. C., & Lemere, C. A. (2025) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00010-z · Cited by 3
Sergio, J. P., Price, A., Snyder, P., Doster, S., Durkin, M., Strenger, J. R., Thompson, L. I., Stradtman, M., Sinoff, S. E., & Alber, J. (2026) · Clinical Interventions in Aging · doi:10.2147/cia.s562194 · Cited by 1
Zeng, J., Gao, Z., Xiong, X., Hou, X., Qin, H., Liu, Y., Bowman, H., Ritchie, C. W., O'Brien, J. T., & Su, L. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241299124 · Cited by 1
Unlocking the therapeutic promise of miRNAs in promoting amyloid-β clearance for Alzheimer's disease
Kaur, V., & Sunkaria, A. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115505 · Cited by 1
Sex Differences in Alzheimer Disease-Related Biomarkers and Dementia Risk
Toopchiani, S. T., Njogu, A. N., Smith, C., Sindi, S., Okoye, O., Watermeyer, T., & Udeh‐Momoh, C. T. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_19 · Cited by 1
Loss of brain insulin production impairs learning and memory in female mice
Baehring, S., O’Leary, T. P., Cen, H. H., Holenka, D., Kim, K., Ajayi, S., Semenov, D., Belmadani, M., Li, H., Mehran, A. E., et al. (2026) · Metabologia · doi:10.1007/s44357-026-00004-8 · Cited by 1
Uzun, Ç., Li, Y., & Liu, S. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70865 · Cited by 1
A novel conditional knock-in mouse model for APOE4-to-APOE3 switching
Ishikawa, R., Yamazaki, Y., Nakazawa, N., Li, X., Tazuma, T., Takebayashi, Y., Nakamori, M., Sotomaru, Y., & Maruyama, H. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107244 · Cited by 1
Chen, L., Chen, C., Hong, Y., Yin, X., Liu, Z., Lu, Y., Chen, Z., Tan, Y., Fu-rong, L., Li, Y., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-25305-4 · Cited by 1
Sex differences in APOE- and PICALM-related cognitive profiles in healthy middle-aged adults
Bednorz, A., Trybek, P., Hoang, M. T., & Religa, D. (2026) · Frontiers in Aging · doi:10.3389/fragi.2025.1694701 · Cited by 1
Tsai, C.-L., & Chang, C.-L. (2026) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2026.106213 · Cited by 1
Bednorz, A., & Religa, D. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1779076 · Cited by 1
Lui, K. K., Wang, X., Dratva, M. A., Lifset, E. T., Stiver, J., Heyworth, N. C., Shen, Q., Thomas, M., DeYoung, P. N., Malhotra, A., et al. (2026) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2026.100581 · Cited by 1
Guan, Y., Cheng, C. H., Khanna, S., Fader, C., Ohene, Y., Wells, J. A., & Koo, B. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03888-y · Cited by 1
Matthews, M., Cooper, R., Dallas, S. L., Khosla, S., Lengyel, K., Nizar, N., South, S. M., van der Meulen, M. C. H., Alliston, T. N., Bouxsein, M., et al. (2026) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjag092 · Cited by 1
Evidence of APOE4‐related brain vulnerabilities in verbal memory systems in midlife women
Wugalter, K. A., Thurston, R., Wu, M.-J., Aizenstein, H., Kamboh, M., Karikari, T., & Maki, P. (2026) · Alzheimer's & Dementia · doi:10.1002/alz.71635 · Cited by 1
Colbeth, H., Corrada, M. M., Mungas, D., Gilsanz, P., George, K. M., Gaied, R., Kawas, C. H., DeCarli, C. S., & Whitmer, R. A. (2026) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2026.100882 · Cited by 1
Role of APOE ɛ4 and ɛ2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity
Colbeth, H., Posis, A. I. B., Rizvi, B. M., DeCarli, C. S., Glymour, M. M., George, K. M., Corrada, M. M., Gilsanz, P., & Whitmer, R. A. (2026) · Neurology · doi:10.1212/wnl.0000000000218596 · Cited by 1
Rousset, R. Z., den Braber, A., Bongers, B., Boonkamp, L., Wilson, D. J., Ligthart, L., Pool, R., Visser, P. J., van der Landen, S. M., de Geus, E. J. C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-78723-2 · Cited by 1
Neurological diseases: Sex and gender evidence in stroke, migraine, and Alzheimer’s dementia
Aggarwal, N. T., & Dafer, R. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816569-0.00011-5 · Cited by 1
Precision medicine: Overview and challenges to clinical implementation
Haga, S. B. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00020-1 · Cited by 2
Schindler, E., & Reddy, P. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15256-6.00001-5 · Cited by 1
Rawat, K., & Garlapally, P. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00040 · Cited by 1
Colombo, D., Zagni, E., Rossini, P. M., Cioccio, L. D., Gragnaniello, D., di Cortemiglia, E. L., Attar, M., Simoni, L., Haggiag, S., & Bernabei, R. (2023) · Health Care For Women International · doi:10.1080/07399332.2023.2223147 · Cited by 1
Precision Nutrition in Aging and Brain Health
Chen, S. T., & Small, G. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00017-1 · Cited by 1
Sex Differences in Alzheimer’s Disease Pathogenesis
Jung, E. S., & Mook‐Jung, I. (2024) · Springer eBooks · doi:10.1007/978-981-97-0130-8_24 · Cited by 1
How Is the X Chromosome Involved in Alzheimer Disease?
Buckley, R. F., & Seto, M. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.2831 · Cited by 1
Konishi, K., Spets, D. S., Fisher, P., Aroner, S. A., Sant, S. M., Prokopenko, D., Lokhande, H. A., Patel, R. P., Aizley, H. G., Smith, B., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251366701 · Cited by 1
Othman, M., Khedr, E., Heikal, S. A., Yousef, M. H., Fawi, G., Elfarrash, S., Salama, S., Abdelshafi, M., Elsheikh, N. G., Tawfik, H. M., et al. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70268 · Cited by 1
Sex, Gender, and Cultural Considerations for Rehabilitation Research with Older Adults
Biscardi, M., & Colantonio, A. (2018) · Handbooks in health, work, and disability · doi:10.1007/978-3-030-03916-5_28 · Cited by 1
Reyes, H. E. C., Contreras, J. R. L., Maravilla, M. C. S., & Romero, C. G. V. (2021) · Crea Ciencia Revista Científica · doi:10.5377/creaciencia.v13i2.11757 · Cited by 1
Xiao, C., Neu, S., & Toga, A. W. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.035 · Cited by 1
Self-citationBrains, biases and amyloid beta: Why the female brain deserves a closer look in Alzheimer’s research
Buckley, R. F. (2024) · The Transmitter · doi:10.53053/ssno9455 · Cited by 1
Gonçalves, A. J., Alotaibi, M., Carlin, A., Chen, Y., Wong, C., Djoukhadar, I., Krokos, G., Jackson, A., Coope, D. J., & Asselin, M. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211061050 · Cited by 1
Self-citationMurphy, A. J., Williamson, J. B., & Lamb, D. G. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_691-1 · Cited by 1
Use of preclinical Alzheimer’s disease trajectories for clinical trial designPreprint
Langhough, R. E., Norton, D., Cody, K. A., Du, L., Jonaitis, E. M., Wilson, R. E., Reyes, R. E. R., Hermann, B. P., Zetterberg, H., & Johnson, S. C. (2025) · medRxiv · doi:10.1101/2025.05.01.25326668 · Cited by 1
Self-citationKuo, M., Yang, W.-C., Chen, Y., Yang, C.-C., Chiu, M., Chen, T., Cheng, J. C., Kuo, S., & Hsu, F.-M. (2025) · Research Square · doi:10.21203/rs.3.rs-6431871/v1 · Cited by 1
Self-citationCho, G., Chen, A., Choi, E., Buxton, O. M., Kay, D. B., & Miner, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.30.656615 · Cited by 1
APOE4 disrupts the central dogma by arresting neuronal proteome dynamicsPreprint
Krogsaeter, E., McKetney, J., Li, L., Liu, I., Richards, A., Subramanyam, V., Yin, K., Gordon, M., Mairal, P. B., Stevenson, E. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738801 · Cited by 1
E-Infrastructures for Neuroscientists: The GAAIN and neuGRID Examples
Orlandi, D., Redolfi, A., Revillard, J., Manset, D., Teipel, S. J., & Frisoni, G. B. (2017) · Springer INdAM series · doi:10.1007/978-3-319-68297-6_11
Self-citationThe interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Pontifex, M. G. (2020) · UEA Digital Repository (University of East Anglia)
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
Reproductive Factors and Risk of Dementia in Natural Postmenopausal Women: a Cross-sectional StudyPreprint
Gan, J., Chen, Z., Liu, S., Wang, F., Wang, X., Hu, W., Du, X., Zhu, H., Ma, L., Shi, Z., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-562858/v1
Levy, S., Guttmann‐Beck, N., & Shweiki, D. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210014
Sex differences in neuroimaging biomarkers in healthy subjects and dementia
Massa, F., Arnaldi, D., Balma, M., Bauckneht, M., Chincarini, A., Ferraro, P. M., Grazzini, M., Lapucci, C., Meli, R., Morbelli, S. D., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819344-0.00009-0
APOE ε4 effects on hippocampal atrophy in the healthy elderly reflect future cognitive declinePreprint
Zhang, L., Calero, M., Medina, M., & Strange, B. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.07.475319
Mitochondrial DNA and Alzheimer's Disease: A First Case-control Study of the Tunisian PopulationPreprint
Salem, N. B., Boussetta, S., de Rojas, I., Moreno–Grau, S., Montrreal, L., Mokni, N., Mahmoud, I., Younes, S., Daouassi, N., Frih-Ayed, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1036952/v1
Self-citationChen, G., Yang, K. Y., & Han, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-70194/v1
Borkowski, K., Pedersen, T. L., Seyfried, N. T., Lah, J. J., Levey, A. I., Hales, C. M., Dammer, E. B., Blach, C., Louie, G., Kaddurah‐Daouk, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-318714/v1
Pasinski, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-04245-5_26
Henderson, V. W., & Kerchner, G. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00017-9
APOE ε 4 carriage associates with improved myocardial performance in older agePreprint
Topriceanu, C., Shah, M., Webber, M. R., Chan, F., Moon, J., Richards, M., Chaturvedi, N., Hughes, A. D., Schott, J. M., O’Regan, D. P., et al. (2022) · medRxiv · doi:10.1101/2022.07.20.22277846
Lombardi, G., Pancani, S., Bagnoli, S., Vannetti, F., Nacmias, B., Sorbi, S., Cecchi, F., & Macchi, C. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07073-4
Zhao, B., Initiative, A. D. N., Ou, Y., Zhang, X.-Y., Fu, Y., & Tan, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230761
Astrocytes Reprogramming for Neurodegenerative Disease Management
Tamegart, L., Hilali, R., Ouaki, H., Rachidi, F., Chakir, I., Ajana, R., Oudghiri, D. E., Draoui, A., Oukhrib, M., Ghachi, H. E., et al. (2023) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-9675-6.ch016
Lin, S., Jiang, L., Wei, K., Yang, J., Cao, X., & Li, C. (2024) · Brain Sciences · doi:10.3390/brainsci14020170
Sex differences in brain aging
Goyal, M. S., Gordon, B. A., & Resnick, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00090-5
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275950
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275956
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275968
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275974
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275953
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275959
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275962
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275977
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275971
Ji, W., An, K., Wang, C., & Wang, S. (2022) · Figshare · doi:10.6084/m9.figshare.21275965
Sobrecarga de cobre y enfermedad de Alzheimer, búsqueda de posibles blancos terapéuticos
Zubillaga, M. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/165188
Oh, E. J., Lee, J. J., Jung, B. K., & Kim, J. K. (2024) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2024.26.32
Major Neurocognitive Disorders Due to Alzheimer’s Disease
Joshi, P., Patel, N., & Gopalakrishna, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_1
Sex/Gender Differences in Dementia and Alzheimer’s Disease
Han, J. W. (2024) · Springer eBooks · doi:10.1007/978-981-97-0130-8_23
Deciphering the impact of astrocytic insulin receptor depletion on Alzheimer's disease pathology
Ezkurdia, A. (2024) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/70017
Metadata
- Authors
- Neu, S. C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Wang, L.-S., Romero, K., Arneric, S. P., Redolfi, A., Orlandi, D., Frisoni, G. B., Au, R., Devine, S., Auerbach, S., Espinosa, A., Boada, M., Ruiz, A., Johnson, S. C., Koscik, R., Wang, J.-J., Hsu, W.-C., Chen, Y.-L., & Toga, A. W.
- Affiliations
- University of Southern California (US)
- University of Washington (US)
- University of Pennsylvania (US)
- Critical Path Institute (US)
- Coalition Against Major Disease, Critical Path Institute, Tucson, Arizona
- Centro San Giovanni di Dio Fatebenefratelli (IT)
- University of Geneva (CH)
- Boston University (US)
- Fundació ACE (ES)
- Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain
- University of Wisconsin–Madison (US)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Corresponding author
- Toga, Arthur W.
- ORCID
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2017-10-01
- Volume
- 74
- Issue
- 10
- Pages
- 1178
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC5759346
- OpenAlex
- W2745657465
- Cited by
- 674
- References
- 74
- Citations by year
- 2026: 74 · 2025: 81 · 2024: 74 · 2023: 93 · 2022: 78 · 2021: 96 · 2020: 69 · 2019: 67 · 2018: 37 · 2017: 3
- FWCI
- 39.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000130, 5u01ag024904-10, n01hc25195-41-0-1, UL1TR001855)
- U.S. Food and Drug Administration (U18FD005320)
- National Institute on Aging (U01-AG-024904, P30AG010129, P30AG010133, P30AG028383, P30AG012300, P50AG005133, U01AG016976, P50AG005131, P50AG005138, P50AG016570, P30AG010124, P50AG016573, RF1AG027161, P50AG047366, P30AG008017, P30AG010161, R01AG033040, P30AG008051, P50AG008702, R01AG016495, P50AG033514, P30AG035982, P50AG005681, P50AG005142, P50AG047270, P30AG019610, P50AG005146, P01AG003991, RF1AG054617, P30AG013846, P50AG005136, P50AG005134, P30AG013854, P50AG025688, P50AG047266, R01AG008122, R01AG027161, U24AG041689, U19AG024904, P01AG026276, P50AG023501, P50AG016574)
- National Heart, Lung, and Blood Institute (N01-HC-025195)
- National Institute of Neurological Disorders and Stroke (R01NS017950)
- National Institute of Biomedical Imaging and Bioengineering (U54EB020406, P41EB015922)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- Alzheimer's disease, apolipoprotein E, APOE ε4, APOE ε2, sex differences, mild cognitive impairment, genetic risk factors
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Female, Humans, Male, Middle Aged, Risk Factors, Sex Characteristics, Logistic Models, Case-Control Studies, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
